IASLC issues new statement on tobacco control and smoking cessation

September 07, 2015

DENVER, Colo. -- The International Association for the Study of Lung Cancer (IASLC) today issued a new statement on Tobacco Control and Smoking Cessation at the 16th World Conference on Lung Cancer (WCLC) in Denver. The statement calls for higher taxes on tobacco products, comprehensive advertising and promotion bans of all tobacco products and product regulation including pack warnings.

"Tax policies that increased the cost of cigarettes have played a prominent role in the reduction of cigarette smoking," said Dr. Kenneth Michael Cummings, Professor, Hollings Cancer Center, Medical University of South Carolina and Co-Chair of IASLC's Tobacco Control and Smoking Cessation Committee.

Cummings and the committee highlighted a recent estimate that showed that doubling the inflation-adjusted price of cigarettes could result in a 33 percent reduction in smoking prevalence. Many low- and middle-income countries can accomplish this by tripling the specific excise tax on tobacco. A low-specific excise tax on tobacco is the main reason that, even after adjustment for purchasing power, cigarettes are about 70 percent cheaper in many low-income countries compared with high-income countries.

Cummings said that smoking is responsible for over 80 percent of all lung cancer cases, while exposure to air pollution, radon, occupational exposures to chemicals and having a family history of lung cancer likely account for the majority of the remaining cases. Worldwide, lung cancer is the leading cause of cancer death.

IASLC urges its members and others around the world to:

  1. Join together to forcefully implement the World Health Organization's Framework Convention on Tobacco Control which has among its key provisions increasing cigarette prices via taxation (to at least 70 percent of the retail price), prohibiting the sale of cigarettes to minors (less than 21 years of age), enacting and enforcing comprehensive cigarette marketing policies, eliminating tobacco use in public locations, mandating graphic warnings labels on cigarette containers, implementing public education campaigns to discourage the use of cigarettes and providing tobacco cessation support.

  2. Adopt legal reforms that allow people who smoke and their families to use the judicial system to hold tobacco manufacturers civilly and criminally accountable for selling products that are deadly when used as intended.

  3. Support programs to prevent smoking initiation habits in children and in youth and recognize that any attempts to induce nicotine consumption in this population should be avoided.

  4. Implement tobacco cessation programs in their clinics, hospitals and cancer centers to assist their patients in achieving the best possible outcomes from their cancer treatment.

  5. Adopt policy measures that recognize the probable differences in the lung cancer risk of alternative nicotine delivery products. Adopting policies that favor less dangerous (non-combustible) forms of nicotine delivery over cigarettes would provide a powerful incentive for people who smoke to move away from cigarettes which in turn would have a profound impact on global lung cancer rates in the coming decades.

To read the entire tobacco declaration, visit: https://www.iaslc.org/sites/default/files/wysiwyg-assets/News/iaslc_2015_tobacco_statement_long.pdf.

About the WCLC:

The WCLC is the world's largest meeting dedicated to lung cancer and other thoracic malignancies, attracting more than 7,000 researchers, physicians and specialists from more than 100 countries. The conference goal is to increase awareness and collaboration so that the latest developments in lung cancer can be understood and implemented throughout the world. Falling under the theme of "Fighting Lung Cancer," the conference will cover a wide range of disciplines and unveil several research studies and clinical trial results. For the first time, IASLC has invited survivors to attend the conference free of charge. For more information on the 2015 WCLC, visit: http://wclc2015.iaslc.org/.

About the IASLC:

The International Association for the Study of Lung Cancer (IASLC) is the only global organization specifically dedicated to the study of lung cancer. Founded in 1974, the association's membership includes nearly 4,000 lung cancer specialists in 80 countries. For more information, visit: https://www.iaslc.org/.

International Association for the Study of Lung Cancer

Related Lung Cancer Articles from Brightsurf:

State-level lung cancer screening rates not aligned with lung cancer burden in the US
A new study reports that state-level lung cancer screening rates were not aligned with lung cancer burden.

The lung microbiome may affect lung cancer pathogenesis and prognosis
Enrichment of the lungs with oral commensal microbes was associated with advanced stage disease, worse prognosis, and tumor progression in patients with lung cancer, according to results from a study published in Cancer Discovery, a journal of the American Association for Cancer Research.

New analysis finds lung cancer screening reduces rates of lung cancer-specific death
Low-dose CT screening methods may prevent one death per 250 at-risk adults screened, according to a meta-analysis of eight randomized controlled clinical trials of lung cancer screening.

'Social smokers' face disproportionate risk of death from lung disease and lung cancer
'Social smokers' are more than twice as likely to die of lung disease and more than eight times as likely to die of lung cancer than non-smokers, according to research presented at the European Respiratory Society International Congress.

Lung cancer therapy may improve outcomes of metastatic brain cancer
A medication commonly used to treat non-small cell lung cancer that has spread, or metastasized, may have benefits for patients with metastatic brain cancers, suggests a new review and analysis led by researchers at St.

Cancer mortality continues steady decline, driven by progress against lung cancer
The cancer death rate declined by 29% from 1991 to 2017, including a 2.2% drop from 2016 to 2017, the largest single-year drop in cancer mortality ever reported.

Cancer-sniffing dogs 97% accurate in identifying lung cancer, according to study in JAOA
The next step will be to further fractionate the samples based on chemical and physical properties, presenting them back to the dogs until the specific biomarkers for each cancer are identified.

Lung transplant patients face elevated lung cancer risk
In an American Journal of Transplantation study, lung cancer risk was increased after lung transplantation, especially in the native (non-transplanted) lung of single lung transplant recipients.

Proposed cancer treatment may boost lung cancer stem cells, study warns
Epigenetic therapies -- targeting enzymes that alter what genes are turned on or off in a cell -- are of growing interest in the cancer field as a way of making a cancer less aggressive or less malignant.

Are you at risk for lung cancer?
This question isn't only for people who've smoked a lot.

Read More: Lung Cancer News and Lung Cancer Current Events
Brightsurf.com is a participant in the Amazon Services LLC Associates Program, an affiliate advertising program designed to provide a means for sites to earn advertising fees by advertising and linking to Amazon.com.